Publications by authors named "Federica Maiorino"

Article Synopsis
  • The study examines the cardiometabolic effects of hypercalcemic primary hyperparathyroidism (HC-PHPT) compared to normocalcemic primary hyperparathyroidism (NC-PHPT) and controls.
  • Patients with HC-PHPT exhibited significant cardiometabolic abnormalities, including higher glucose, cholesterol, and blood pressure levels, as well as more frequent cardiovascular events compared to both NC-PHPT patients and controls.
  • The findings suggest that NC-PHPT does not show these cardiovascular issues, indicating that hypercalcemia may play a key role in the development of cardiometabolic disorders in HC-PHPT.
View Article and Find Full Text PDF

Context: Hyponatremia is associated with increased risk of osteoporosis and fractures. The impact of hyponatremia on non-invasive indices of bone quality, however, is unknown.

Objective: To evaluate whether trabecular bone microarchitecture, assessed non-invasively by trabecular bone score (TBS), is altered in patients with hyponatremia.

View Article and Find Full Text PDF

Context: The impairment of bone microarchitecture is a key determinant of skeletal fragility in patients with chronic kidney disease (CKD). The trabecular bone score (TBS) has been developed as a reliable noninvasive index of bone quality. However, its utility in this setting is still debated.

View Article and Find Full Text PDF

Introduction: There are few data regarding the clinical outcome of patients with parathyroid carcinoma (PC) and atypical adenoma (AA) after surgery. Aim of our study was to investigate disease recurrence and mortality rate as well as their predictors in a series of patients with PC or AA.

Methods: Clinical and biochemical parameters, histological features, incidence of disease recurrence and mortality rate were retrospectively assessed in 39 patients (51% males, mean age 56.

View Article and Find Full Text PDF

Despite the current debate on the best therapeutic approach, i.e. symptomatic vs intensive strategy, one zoledronate (Zol) infusion is effective in most patients with Paget's disease of bone (PDB), whereas few need retreatment, whose predictors are not well established.

View Article and Find Full Text PDF